Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Marek

Showing results (21-30 of 600) with videos related to

Pageof 60
Sort By:
Organon|January 1, 1971
[Not Available]J Marek
Die Pharmazie|December 1, 1980
Effects of single intramuscular administration of various preparations of corticosteroids on bentonite-induced oedema of rat hind pawJ Marek
Sudhoffs Archiv|January 1, 1971
[Keppler's experiments as precursors of Young's and Fresnel's experiments. Role of the operture camera in the development of physical optics]J Marek
Sbornik Lekarsky|February 1, 1987
[Incidence and morphology of analgesic nephropathy 1972-1981]J Marek
Current Topics in Behavioral Neurosciences|August 24, 2017
Interactions of Hallucinogens with the Glutamatergic System: Permissive Network Effects Mediated Through Cortical Layer V Pyramidal NeuronsGerard J Marek
Neuroscience Letters|May 20, 2008
Cortical 5-hydroxytryptamine2A-receptor mediated excitatory synaptic currents in the rat following repeated daily fluoxetine administrationGerard J Marek
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|February 26, 2008
Regulation of rat cortical 5-hydroxytryptamine2A receptor-mediated electrophysiological responses by repeated daily treatment with electroconvulsive shock or imipramineGerard J Marek
Current Pharmaceutical Design|June 6, 2015
When is a Proof-of-Concept (POC) not a POC? Pomaglumetad (LY2140023) as a Case Study for Antipsychotic EfficacyGerard J Marek
Neuropharmacology|March 28, 2009
Activation of adenosine(1) (A(1)) receptors suppresses head shakes induced by a serotonergic hallucinogen in ratsGerard J Marek
International Review of Neurobiology|March 14, 2007
Serotonin and dopamine interactions in rodents and primates: implications for psychosis and antipsychotic drug developmentGerard J Marek
Pageof 60

Showing results (21-30 of 600) with videos related to

Sort By:
Pageof 60
Organon|January 1, 1971
[Not Available]J Marek
Die Pharmazie|December 1, 1980
Effects of single intramuscular administration of various preparations of corticosteroids on bentonite-induced oedema of rat hind pawJ Marek
Sudhoffs Archiv|January 1, 1971
[Keppler's experiments as precursors of Young's and Fresnel's experiments. Role of the operture camera in the development of physical optics]J Marek
Sbornik Lekarsky|February 1, 1987
[Incidence and morphology of analgesic nephropathy 1972-1981]J Marek
Current Topics in Behavioral Neurosciences|August 24, 2017
Interactions of Hallucinogens with the Glutamatergic System: Permissive Network Effects Mediated Through Cortical Layer V Pyramidal NeuronsGerard J Marek
Neuroscience Letters|May 20, 2008
Cortical 5-hydroxytryptamine2A-receptor mediated excitatory synaptic currents in the rat following repeated daily fluoxetine administrationGerard J Marek
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|February 26, 2008
Regulation of rat cortical 5-hydroxytryptamine2A receptor-mediated electrophysiological responses by repeated daily treatment with electroconvulsive shock or imipramineGerard J Marek
Current Pharmaceutical Design|June 6, 2015
When is a Proof-of-Concept (POC) not a POC? Pomaglumetad (LY2140023) as a Case Study for Antipsychotic EfficacyGerard J Marek
Neuropharmacology|March 28, 2009
Activation of adenosine(1) (A(1)) receptors suppresses head shakes induced by a serotonergic hallucinogen in ratsGerard J Marek
International Review of Neurobiology|March 14, 2007
Serotonin and dopamine interactions in rodents and primates: implications for psychosis and antipsychotic drug developmentGerard J Marek
Pageof 60